Last update 08 May 2025

JNJ-26113100

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesCongenital DisordersSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Moderate Atopic Dermatitis
Originator Organization
Johnson & Johnson Pharmaceutical Research & Development LLC
Active Organization-
Inactive Organization
Johnson & Johnson Pharmaceutical Research & Development LLC
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with JNJ-26113100
NCT00455429
/ TerminatedPhase 2
A Double-Blind, Randomized, Placebo-Controlled, Sequential Cohort Exploratory Study of the Safety and Efficacy of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis That is Moderate in Severity
100 Clinical Results associated with JNJ-26113100
Login to view more data
100 Translational Medicine associated with JNJ-26113100
Login to view more data
100 Patents (Medical) associated with JNJ-26113100
Login to view more data
100 Deals associated with JNJ-26113100
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Moderate Atopic DermatitisPhase 2
United States
Johnson & Johnson Pharmaceutical Research & Development LLC
01 Apr 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT00455429 (CTgov)
Phase 2
Moderate Atopic Dermatitis
84
Placebo
(Placebo)
stugdqubtj(kktorxejmj) = lgyrqlcuuz wjmxvboeir (lkomskffxr, ffhofduxql - qylhrtkrrs)
View more
-
01 Jul 2013
(JNJ-26113100 (50 mg) Once Daily)
stugdqubtj(kktorxejmj) = ohtqfsjrxp wjmxvboeir (lkomskffxr, srykctlrwt - hvrwtsasrq)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free